Mental health concerns like anxiety and depression were present across all medications, though at lower frequencies (mainly under 1%), with depression mentioned in 1.57% of Wegovy posts
This variability highlights why sourcing options, program eligibility, and clinician guidance are essential for practical affordability
When the FDA removed tirzepatide in December 2024 and semaglutide in February 2025, they didnt just update a websitethey triggered a legal shutdown of the primary revenue stream for hundreds of facilities
Im not just talking about long-term side effects (which we will get into in just a minute), Im talking about short-term side effects as well
GLP-1 RA Drug Concerns Ozempic (semaglutide) is the most widely used of this new class of medications, and was originally introduced by Novo Nordisk as a treatment for Type 2 diabetes
These do not influence our content moderation policies in any way, though ProductReview.com.au may earn commissions for products/services purchased via affiliate links.
